408 related articles for article (PubMed ID: 25474204)
21. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
[No Abstract] [Full Text] [Related]
22. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
[TBL] [Abstract][Full Text] [Related]
23. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
Long JZ; Nomura DK; Cravatt BF
Chem Biol; 2009 Jul; 16(7):744-53. PubMed ID: 19635411
[TBL] [Abstract][Full Text] [Related]
24. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.
Seillier A; Dominguez Aguilar D; Giuffrida A
Pharmacol Biochem Behav; 2014 Sep; 124():153-9. PubMed ID: 24911644
[TBL] [Abstract][Full Text] [Related]
25. Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.
Griebel G; Pichat P; Beeské S; Leroy T; Redon N; Jacquet A; Françon D; Bert L; Even L; Lopez-Grancha M; Tolstykh T; Sun F; Yu Q; Brittain S; Arlt H; He T; Zhang B; Wiederschain D; Bertrand T; Houtmann J; Rak A; Vallée F; Michot N; Augé F; Menet V; Bergis OE; George P; Avenet P; Mikol V; Didier M; Escoubet J
Sci Rep; 2015 Jan; 5():7642. PubMed ID: 25560837
[TBL] [Abstract][Full Text] [Related]
26. Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.
Zhong P; Wang W; Pan B; Liu X; Zhang Z; Long JZ; Zhang HT; Cravatt BF; Liu QS
Neuropsychopharmacology; 2014 Jun; 39(7):1763-76. PubMed ID: 24476943
[TBL] [Abstract][Full Text] [Related]
27. Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice.
Aliczki M; Zelena D; Mikics E; Varga ZK; Pinter O; Bakos NV; Varga J; Haller J
Horm Behav; 2013 May; 63(5):752-8. PubMed ID: 23578952
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
[TBL] [Abstract][Full Text] [Related]
29. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.
Trigo JM; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1815-22. PubMed ID: 26490035
[TBL] [Abstract][Full Text] [Related]
31. Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses.
Wang Y; Gu N; Duan T; Kesner P; Blaskovits F; Liu J; Lu Y; Tong L; Gao F; Harris C; Mackie K; Li J; Tan Q; Hill MN; Yuan Z; Zhang X
Mol Psychiatry; 2017 Feb; 22(2):215-226. PubMed ID: 27001616
[TBL] [Abstract][Full Text] [Related]
32. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.
Zhang X; Thayer SA
Neuropharmacology; 2018 Jan; 128():269-281. PubMed ID: 29061509
[TBL] [Abstract][Full Text] [Related]
33. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
[TBL] [Abstract][Full Text] [Related]
34. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
Ramesh D; Gamage TF; Vanuytsel T; Owens RA; Abdullah RA; Niphakis MJ; Shea-Donohue T; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
[TBL] [Abstract][Full Text] [Related]
35. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
Wang J; Zhang X; Yang C; Zhao S
Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
Elife; 2022 Oct; 11():. PubMed ID: 36217821
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice.
Kamimura R; Hossain MZ; Unno S; Ando H; Masuda Y; Takahashi K; Otake M; Saito I; Kitagawa J
J Oral Sci; 2018 Mar; 60(1):37-44. PubMed ID: 29503395
[TBL] [Abstract][Full Text] [Related]
39. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
